JP2022532761A - 異数性の迅速検出法 - Google Patents

異数性の迅速検出法 Download PDF

Info

Publication number
JP2022532761A
JP2022532761A JP2021568507A JP2021568507A JP2022532761A JP 2022532761 A JP2022532761 A JP 2022532761A JP 2021568507 A JP2021568507 A JP 2021568507A JP 2021568507 A JP2021568507 A JP 2021568507A JP 2022532761 A JP2022532761 A JP 2022532761A
Authority
JP
Japan
Prior art keywords
cancer
amplicon
sample
primer
aneuploidy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021568507A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022532761A5 (https=
Inventor
バート フォーゲルシュタイン
ケネス ダブリュ． キンズラー
クリストファー デュヴィル
ニコラス パパドプロス
クリスティアン トマセッティ
Original Assignee
ザ・ジョンズ・ホプキンス・ユニバーシティー
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ザ・ジョンズ・ホプキンス・ユニバーシティー filed Critical ザ・ジョンズ・ホプキンス・ユニバーシティー
Publication of JP2022532761A publication Critical patent/JP2022532761A/ja
Publication of JP2022532761A5 publication Critical patent/JP2022532761A5/ja
Priority to JP2025173346A priority Critical patent/JP2026012754A/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
    • C12Q2535/122—Massive parallel sequencing
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
    • C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
    • C12Q2537/16—Assays for determining copy number or wherein the copy number is of special importance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Databases & Information Systems (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Artificial Intelligence (AREA)
  • Epidemiology (AREA)
  • Evolutionary Computation (AREA)
  • Bioethics (AREA)
  • Public Health (AREA)
  • Software Systems (AREA)
JP2021568507A 2019-05-17 2020-05-15 異数性の迅速検出法 Pending JP2022532761A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025173346A JP2026012754A (ja) 2019-05-17 2025-10-15 異数性の迅速検出法

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201962849662P 2019-05-17 2019-05-17
US62/849,662 2019-05-17
US201962905327P 2019-09-24 2019-09-24
US62/905,327 2019-09-24
US202062971050P 2020-02-06 2020-02-06
US62/971,050 2020-02-06
PCT/US2020/033209 WO2020236625A2 (en) 2019-05-17 2020-05-15 Rapid aneuploidy detection

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025173346A Division JP2026012754A (ja) 2019-05-17 2025-10-15 異数性の迅速検出法

Publications (2)

Publication Number Publication Date
JP2022532761A true JP2022532761A (ja) 2022-07-19
JP2022532761A5 JP2022532761A5 (https=) 2023-05-17

Family

ID=71741878

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021568507A Pending JP2022532761A (ja) 2019-05-17 2020-05-15 異数性の迅速検出法
JP2025173346A Pending JP2026012754A (ja) 2019-05-17 2025-10-15 異数性の迅速検出法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025173346A Pending JP2026012754A (ja) 2019-05-17 2025-10-15 異数性の迅速検出法

Country Status (14)

Country Link
US (1) US20220259668A1 (https=)
EP (1) EP3969616A2 (https=)
JP (2) JP2022532761A (https=)
KR (1) KR20220021909A (https=)
CN (1) CN114207147A (https=)
AU (2) AU2020279106B2 (https=)
BR (1) BR112021023025A2 (https=)
CA (1) CA3140850A1 (https=)
CL (1) CL2021003030A1 (https=)
CO (1) CO2021017009A2 (https=)
IL (1) IL288081A (https=)
MX (1) MX2021013834A (https=)
SG (1) SG11202112680XA (https=)
WO (1) WO2020236625A2 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3969616A2 (en) * 2019-05-17 2022-03-23 The Johns Hopkins University Rapid aneuploidy detection
WO2022155409A1 (en) * 2021-01-14 2022-07-21 Case Western Reserve University Methods of detecting high risk barrett's esophagus with dysplasia, and esophageal adenocarcinoma
US20260071279A1 (en) * 2022-06-10 2026-03-12 The Johns Hopkins University Methods for identifying cns cancer in a subject
CN114990202B (zh) * 2022-07-29 2022-09-30 普瑞基准科技（北京）有限公司 Snp位点在评估基因组异常的应用及评估基因组异常的方法
WO2024155909A1 (en) * 2023-01-19 2024-07-25 The Johns Hopkins University Methods for identifying ovarian cancer in a subject
EP4662335A2 (en) * 2023-02-09 2025-12-17 The Translational Genomics Research Institute Amplicon-based approach for detecting differences in human dna fragmentation patterns between cancer and non-cancer samples
AU2024216779A1 (en) * 2023-02-09 2025-08-28 The Translational Genomics Research Institute Amplicon-based approach for detecting differences in non-human dna fragmentation patterns between cancer and non-cancer samples
KR102630597B1 (ko) * 2023-08-22 2024-01-29 주식회사 지놈인사이트테크놀로지 종양 정보를 활용한 미세 잔존 질환 탐지 방법 및 장치

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019067092A1 (en) * 2017-08-07 2019-04-04 The Johns Hopkins University METHODS AND SUBSTANCES FOR THE EVALUATION AND TREATMENT OF CANCER

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006214800B2 (en) * 2005-02-16 2012-06-07 Cy O'connor Erade Village Foundation Methods of genetic analysis involving the amplification of complementary duplicons
EP1712639B1 (en) 2005-04-06 2008-08-27 Maurice Stroun Method for the diagnosis of cancer by detecting circulating DNA and RNA
JP2008173083A (ja) * 2007-01-22 2008-07-31 Nippon Software Management Kk Ｄｎａタグによる生物の同定方法
CA2868836C (en) * 2012-03-26 2019-08-06 The Johns Hopkins University Rapid aneuploidy detection
JP6474058B2 (ja) * 2012-09-13 2019-02-27 御木本製薬株式会社 エンドセリン−１産生抑制剤
DK3201361T3 (da) * 2014-10-01 2020-05-18 Chronix Biomedical Fremgangsmåder til kvantificering af cellefrit DNA
JP6929778B2 (ja) * 2015-01-15 2021-09-01 グッド スタート ジェネティクス， インコーポレイテッド 着床前遺伝子スクリーニングにおける一塩基多型を用いた品質管理方法
US20160275240A1 (en) * 2015-02-18 2016-09-22 Nugen Technologies, Inc. Methods and compositions for pooling amplification primers
US11319594B2 (en) * 2016-08-25 2022-05-03 Resolution Bioscience, Inc. Methods for the detection of genomic copy changes in DNA samples
EP3969616A2 (en) * 2019-05-17 2022-03-23 The Johns Hopkins University Rapid aneuploidy detection

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019067092A1 (en) * 2017-08-07 2019-04-04 The Johns Hopkins University METHODS AND SUBSTANCES FOR THE EVALUATION AND TREATMENT OF CANCER

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
PNAS, vol. 115, no. 8, JPN6024017495, 2018, pages 1871 - 1876, ISSN: 0005320046 *
人工知能学会誌, vol. 28巻 4号, JPN6024017494, 2013, pages 649 - 659, ISSN: 0005320048 *
見て試してわかる機械学習アルゴリズムの仕組み 機械学習図鑑, vol. 初版, JPN6024017496, April 2019 (2019-04-01), pages 71, ISSN: 0005320047 *

Also Published As

Publication number Publication date
KR20220021909A (ko) 2022-02-22
EP3969616A2 (en) 2022-03-23
MX2021013834A (es) 2022-06-29
US20220259668A1 (en) 2022-08-18
CL2021003030A1 (es) 2022-10-07
WO2020236625A2 (en) 2020-11-26
CA3140850A1 (en) 2020-11-26
JP2026012754A (ja) 2026-01-27
AU2020279106A1 (en) 2021-12-09
CN114207147A (zh) 2022-03-18
CO2021017009A2 (es) 2022-04-08
AU2026201955A1 (en) 2026-04-16
WO2020236625A3 (en) 2021-02-11
BR112021023025A2 (pt) 2022-01-04
AU2020279106B2 (en) 2025-12-18
SG11202112680XA (en) 2021-12-30
IL288081A (en) 2022-01-01

Similar Documents

Publication Publication Date Title
JP2022532761A (ja) 異数性の迅速検出法
US20250066860A1 (en) Methods and materials for assessing and treating cancer
JP6700333B2 (ja) ヘテロ接合性の消失（ｌｏｓｓ ｏｆ ｈｅｔｅｒｏｚｙｇｏｓｉｔｙ）を評価するための方法および材料
CN109207594B (zh) 一种基于二代测序的通过血浆检测微卫星稳定状态和基因组变化的方法
JP2022031753A (ja) 血漿による胎児または腫瘍のメチロームの非侵襲的決定
ES2911613T3 (es) Análisis de patrones de metilación de haplotipos en tejidos en una mezcla de ADN
JP2022519159A (ja) 循環細胞の分析方法
WO2016008451A1 (en) Methylation pattern analysis of tissues in dna mixture
WO2019047577A1 (zh) 一种微卫星不稳定性的测序数据分析方法、装置及计算机可读介质
US20260078452A1 (en) Methods of cancer detection using extraembryonically methylated cpg islands
WO2023226939A1 (zh) 用于检测结直肠癌淋巴结转移的甲基化生物标记物及其应用
HK40070119A (en) Rapid aneuploidy detection
EA050254B1 (ru) Быстрое обнаружение анеуплоидии
CN106011263B (zh) 用于检测与胃癌相关的ndrg4基因甲基化程度的试剂盒及其应用
Paracchini Analysis of Defects in Transcriptional Regulation Mechanisms in High-Grade Serous Ovarian Cancer and Their Correlation with Clinic-Pathological Features
HK40129938A (zh) 用於评估和治疗癌症的方法和材料
CN121219428A (zh) 用于评定液体活检样品中循环肿瘤dna分数的方法和系统
Nagy Biomedical Papers
HK40038488B (zh) 用於评估和治疗癌症的方法和材料
HK40038488A (en) Methods and materials for assessing and treating cancer

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20220119

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230509

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230509

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20230705

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240412

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240509

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240808

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20241010

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20241224

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250407

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250616